From: Variation in TMEM106B in chronic traumatic encephalopathy
 | Controls (n = 376) | CTE cases (n = 86) | P Value |
---|---|---|---|
Age (mean ± SD (range)) | 61.02 ± 10.2 (35–90) | 57.02 ± 21.19 (17–89) | 0.01 |
Years of exposure (mean ± SD (range)) | – | 13.49 ± 5.47 (1–31) | – |
Cases with dementia (%) | – | 33 (38.4%) | – |
TMEM106B MAF | 43.2% | 41.9% | 0.71 |
rs3173615 genotypes | Â | Â | 0.74 |
 CC (%) | 123 (32.7%) | 29 (33.7%) |  |
 CG (%) | 181 (48.1%) | 42 (48.8%) |  |
 GG (%) | 72 (19.1%) | 15 (17.4%) |  |
CERAD (mean ± SD) | – | 0.29 ± 0.50 | – |
Cases with TDP-43 (%) | – | 27 (31.4%) | – |
AT8 Quartiles (positive pixel density/mm2 ± SD) |  | ||
 1 | – | 283 ± 221 |  |
 2 | – | 2863 ± 1362 |  |
 3 | – | 10,438 ± 3715 |  |
 4 | – | 65,914 ± 62,629 |  |
CD68 Quartiles (Positive cell/mm2 ± SD) | |||
 1 | – | 93 ± 15 |  |
 2 | – | 138 ± 10 |  |
 3 | – | 171 ± 10 |  |
 4 | – | 226 ± 31 |  |